PsychoGenics is a leading authority in preclinical research for pain disorders, dedicated to advancing the development of effective therapies to alleviate pain and improve patient outcomes. PsychoGenics is equipped with state-of-the-art facilities and resources to support pain research projects of any scale. Whether you need a small, highly focused study or a larger investigation, our infrastructure and capabilities deliver actionable data and high-quality results. With our extensive involvement in the Preclinical Screening Platform for Pain (PSPP) NIH project, we provide a comprehensive range of services, addressing an array of pain indications and offering superior insight.